|
Forecast
Period
|
2025-2029
|
|
Market
Size (2023)
|
USD
11.98 Billion
|
|
CAGR
(2024-2029)
|
7.30%
|
|
Fastest
Growing Segment
|
Hospitals
& Clinics
|
|
Largest
Market
|
North America
|
|
Market
Size (2029)
|
USD
18.20 Billion
|
Market Overview
Global Intravascular Stents
Market was valued at USD 11.98 Billion in 2023 and is anticipated to witness a steady growth in the forecast period with a CAGR of 7.30% through 2029. Intravascular
stents are medical devices designed to support and maintain the patency
(openness) of blood vessels, typically arteries or veins, within the human
body. They are used in a medical procedure called angioplasty, which is a
minimally invasive technique for treating various vascular conditions,
especially those related to atherosclerosis and arterial narrowing.
Intravascular stents are instrumental in restoring proper blood flow through
vessels and preventing complications associated with vascular blockages. Intravascular
stents are primarily used to treat vascular conditions, most commonly in the
coronary arteries (coronary stents) and peripheral arteries (peripheral
stents), but they can also be used in other vessels throughout the body. Stents
are typically tubular, mesh-like structures made from biocompatible materials,
such as stainless steel, cobalt-chromium alloys, nickel-titanium (Nitinol), or
bioresorbable polymers. They can be bare metal or coated with drug-eluting
coatings. Stents are placed inside the affected blood vessel during
an angioplasty procedure. First, a catheter with a deflated balloon at its tip
is threaded into the blocked or narrowed vessel. The balloon is inflated to
compress the plaque or obstruction against the vessel wall, restoring blood
flow. Then, the stent, which is mounted on the balloon, is expanded to act as a
scaffold to keep the vessel open.
The global aging population
is more prone to cardiovascular diseases. As the elderly population increases,
so does the demand for intravascular stents. Ongoing research and
innovation in stent design, materials, and coatings lead to the development of
more effective and safer stents, which drive market growth. Greater
awareness of cardiovascular health improved diagnostic techniques, and regular
health screenings have led to earlier detection of cardiovascular conditions,
resulting in more stent procedures. Factors such as sedentary
lifestyles, poor dietary habits, and increased stress contribute to the rising
incidence of cardiovascular diseases, boosting the demand for stents. An
increasing emphasis on tracking patient outcomes and real-world evidence to
determine the effectiveness of different stent types and materials is driving
innovation.
Key Market Drivers
Technological Advancements
Drug-eluting stents are coated with medications that
are slowly released to inhibit tissue regrowth and reduce restenosis
(re-narrowing of the treated vessel). The development of various drug coatings,
such as sirolimus and paclitaxel, has significantly improved the long-term
efficacy of stents in preventing restenosis. Bioabsorbable stents are designed
to gradually dissolve in the body over time, leaving behind only natural
tissue. These stents eliminate some of the long-term issues associated with
metallic stents, such as the risk of late stent thrombosis and potential
interference with future procedures or imaging.
Hybrid stent designs combine the benefits of both
balloon-expandable and self-expanding stents. These stents provide precise
deployment and radial strength while also adapting to vessel anatomy. Some DES now use bioresorbable polymer
coatings to release drugs. These coatings are absorbed by the body over time,
reducing the risk of chronic inflammation and long-term complications. 3D
printing technology is being used to create patient-specific stents tailored to
an individual's unique vascular anatomy. This can lead to more effective and
personalized treatment. Nanotechnology is being employed to improve the
biocompatibility of stents, allowing for better integration with vascular
tissue and reduced inflammation. Radiopaque stents are designed to be highly
visible under fluoroscopy, aiding in precise placement. Radiolucent stents are
transparent under X-ray, enabling better visualization of vessel structures. Advancements
in coating technologies, such as nano-coatings and bioactive coatings, enhance
the release of drugs and improve stent performance.
Reducing the thickness of stent struts minimizes the
obstruction to blood flow, reduces the risk of restenosis, and improves
deliverability during the procedure. These stents use biodegradable polymers
that are gradually absorbed by the body. This technology minimizes long-term
inflammation and complications associated with polymer coatings. Innovations in
imaging and 3D modeling allow for the creation of stents that precisely match a
patient's vascular anatomy, reducing complications and optimizing treatment.
These devices combine angioplasty balloons with drug coatings to provide
localized drug delivery to the treated area. They are used in conjunction with
stents or as an alternative treatment option. The use of advanced materials and
alloys, such as nitinol, in stent construction allows for improved flexibility,
conformability, and durability. Stent manufacturers are exploring the
integration of sensors into stents, enabling remote monitoring of stent
performance and patient condition. This factor will help in the development of
the Global Intravascular
Stents Market.
Increasing Awareness and Diagnosis
Greater awareness of cardiovascular health and the
availability of routine screenings and diagnostic tests have led to the early
detection of cardiovascular conditions. This includes coronary artery disease,
peripheral artery disease, and other vascular disorders that may require stent
implantation. With improved awareness, individuals at risk of cardiovascular
diseases are more likely to seek medical attention when they experience
symptoms or risk factors. Early intervention can prevent disease progression
and may involve the use of intravascular stents.
Timely diagnosis and treatment can reduce the severity
of the disease, lower the risk of complications, and improve patient outcomes.
Stent placement is often a minimally invasive and effective solution for
managing these conditions. Increased awareness often leads to better patient
education about cardiovascular diseases and available treatment options,
including stent placement. Informed patients are more likely to participate in
their healthcare decisions. Awareness campaigns and improved public knowledge
about cardiovascular diseases lead to more referrals from primary care
physicians and general practitioners to specialists who may recommend stent
procedures when appropriate. Increased awareness encourages individuals to
manage modifiable risk factors, such as smoking, unhealthy diet, and sedentary
lifestyles, which can contribute to the prevention of cardiovascular diseases
and reduce the need for stent interventions.
National and regional health organizations often run
screening programs and campaigns that target at-risk populations. These
programs lead to increased diagnosis and may result in the use of stents as a
treatment option. Global health initiatives, including World Heart Day and
World Stroke Day, play a role in raising awareness about the burden of
cardiovascular diseases, promoting prevention, and encouraging timely treatment
when necessary. Local health departments, clinics, and healthcare organizations
often engage in community outreach efforts to educate the public about heart
health and the importance of early diagnosis and treatment. Awareness efforts
also help reduce the stigma associated with cardiovascular diseases, making it
more acceptable for individuals to discuss symptoms and seek treatment. A
growing focus on cardiovascular health has led to increased research and
innovation in the field of intravascular stents, resulting in more effective
and safer stent designs and technologies. This factor will pace up the demand
of the Global Intravascular
Stents Market.
Increasing Aging Population
As individuals age, their
risk of developing cardiovascular diseases, such as coronary artery disease,
peripheral artery disease, and aortic stenosis, significantly increases. These
conditions often require the use of intravascular stents for treatment. Older
adults are more likely to have chronic health conditions, such as diabetes,
hypertension, and hyperlipidemia, which are risk factors for cardiovascular
diseases. These conditions may necessitate the use of stents to manage and
treat vascular complications. The aging process is associated with changes in
blood vessels, such as atherosclerosis and arterial stiffening, which can lead
to vascular obstructions. Stents are commonly used to address these age-related
changes. Older patients often have complex medical histories, including prior
cardiovascular interventions or comorbid conditions, making stent procedures a
valuable treatment option to manage their healthcare needs.
Advances in healthcare and
medical treatments have increased life expectancy, resulting in a larger aging
population. As individuals live longer, they are more likely to experience
age-related cardiovascular issues that may require stent interventions. Older
adults are increasingly considered surgical candidates for stent procedures, as
advancements in healthcare allow for improved outcomes and safety for elderly
patients. The elderly population often prefers minimally invasive procedures
like stent placement, as they typically involve shorter recovery times and
reduced trauma compared to open surgeries. Aging patients may undergo stent
procedures as preventive interventions to address potential blockages or
stenoses in their arteries before they lead to severe complications.
Stent placement can allow
older adults to maintain an active and independent lifestyle, reducing the
impact of cardiovascular conditions on daily activities. Older individuals,
particularly in developed countries, have better access to healthcare,
including specialized cardiology services that offer stent procedures. The
aging population benefits from post-stent care, which helps manage their
cardiovascular health and reduce the risk of complications or revascularization
procedures. With longer life expectancies, older patients are more inclined to
educate themselves about cardiovascular health and the available treatment
options, including stent procedures. This factor will accelerate the demand of the Global
Intravascular Stents Market.
Download Free Sample Report
Key Market Challenges
Post-Market
Surveillance and Reporting
The need for long-term
follow-up data to assess the safety and efficacy of intravascular stents is a
considerable challenge. Stents are implanted for extended periods, and adverse
events or complications may not become evident until years after the procedure.
The intravascular stents market serves diverse patient populations with varying
risk factors, comorbidities, and anatomical characteristics. This diversity
complicates data collection and analysis, making it challenging to draw broad
conclusions about stent performance. There is variability in how adverse events
and complications are reported and recorded among different healthcare
institutions and regions. This can hinder the aggregation and analysis of
post-market data. Adverse events associated with stent use may be
underreported, either due to lack of awareness or reluctance on the part of
healthcare providers or patients. This can lead to incomplete data and an
inaccurate assessment of stent safety. Variations in regulatory requirements
and post-market surveillance expectations in different countries or regions can
complicate the harmonization of data collection and reporting practices. Collating
and integrating data from various sources, including electronic health records,
clinical studies, and device registries, can be technically challenging,
especially in cases where healthcare systems lack interoperability. Stringent
patient privacy regulations and concerns can limit the sharing of patient data
across institutions and borders, hindering comprehensive post-market
surveillance efforts.
Market
Saturation
The global intravascular
stents market is relatively mature, with a well-established presence of
multiple manufacturers and a wide range of stent products. This maturity can
limit opportunities for significant growth. Market saturation often leads to
intense competition among stent manufacturers, resulting in pricing pressures
and reduced profit margins. In mature markets, there may be less room for
groundbreaking innovations, as many of the key technological advancements have
already been introduced. This can limit opportunities for differentiation. Most
healthcare facilities, especially in developed regions, are already equipped to
perform stent procedures, and many physicians are experienced in stent
implantation. This saturation limits the expansion of the customer base. As the
market becomes saturated, the overall growth rate may slow down, making it
challenging for companies to achieve substantial revenue increases. Fierce
competition often leads to price competition, which can impact the
profitability of stent manufacturers. Lower prices may be required to gain or
maintain market share.
Key Market Trends
Customization
and Personalization
Advancements in medical imaging, such as
computed tomography (CT), angiography and intravascular ultrasound (IVUS),
allow for the creation of patient-specific stents. These stents are designed to
match the unique vascular anatomy of each patient, improving the precision and
effectiveness of the intervention. 3D
printing technology is being used to manufacture stents that are customized to
fit individual patients. These stents are designed based on the specific
dimensions and geometry of a patient's vessels, potentially reducing
complications, and improving stent performance. Personalization extends to the
choice of coatings and drugs used in drug-eluting stents (DES). Different
patients may respond differently to various coatings and drugs, and the ability
to customize these elements can optimize patient outcomes. Customized stent
solutions align with the principles of precision medicine, where medical
decisions and treatments are tailored to the genetic, molecular, and clinical
characteristics of individual patients. Personalization in the intravascular
stents market involves assessing an individual patient's risk factors,
comorbidities, and specific cardiovascular conditions. This information helps
guide stent selection and treatment decisions.
Segmental Insights
Type Insights
Based on Type, Drug Eluting Stents have emerged as the dominating segment in Global Intravascular Stents Market in 2023. Drug-eluting
stents are designed to release drugs that inhibit tissue regrowth in the
stented area, reducing the risk of restenosis (renarrowing of the vessel). As a
result, DES have been shown to have superior clinical outcomes compared to
bare-metal stents (BMS), with lower rates of restenosis and target lesion
revascularization. Because of their ability to prevent restenosis, DES reduce
the need for repeat procedures, such as angioplasty or additional stent
implantation. This not only improves patient outcomes but also reduces the
economic burden on healthcare systems. DES often have special coatings or drugs
that help prevent the formation of blood clots (thrombosis) inside the stent,
reducing the risk of in-stent thrombosis and its associated complications. DES
are particularly effective in treating complex lesions, such as long and
calcified blockages, which are challenging to address with BMS. This makes DES
a preferred choice for many interventional procedures. The DES segment offers a
wide array of choices, including various drug types (e.g., sirolimus,
paclitaxel, zotarolimus) and stent designs, allowing healthcare providers to
tailor the treatment to the patient's specific needs.
Product Insights
Based on Product, Coronary Stents have emerged as the dominating segment in Global Intravascular Stents Market in 2023. Coronary artery disease (CAD) is one of
the most common cardiovascular diseases worldwide. It involves the narrowing or
blockage of the coronary arteries that supply blood to the heart muscle. Given
the high incidence of CAD, there is a substantial demand for coronary stents to
treat this condition. Coronary stents are frequently used in life-threatening
situations, such as heart attacks (myocardial infarctions) or unstable angina.
These emergency situations require prompt intervention to restore blood flow to
the heart muscle, and coronary stents play a critical role in this regard. Coronary
stent implantation procedures, both elective and emergency, are
well-established and widely practiced in cardiology. Physicians have extensive
experience and training in performing these procedures, which contributes to
their popularity. Clinical trials and studies have consistently shown the
effectiveness of coronary stents in improving patient outcomes, reducing
symptoms, and preventing complications associated with CAD, such as heart
attacks. Continuous research and development efforts in the field of
coronary stents have led to innovations in design, materials, and drug-eluting
technologies, resulting in safer and more effective stents. These advancements
enhance the appeal of coronary stents to both healthcare professionals and
patients.
Download Free Sample Report
Regional Insights
Based on Region, North America have emerged as the dominating region in the Global Intravascular Stents Market in 2023. North
America, particularly the United States and Canada, boasts a highly developed
and advanced healthcare infrastructure. This infrastructure includes
state-of-the-art hospitals, well-equipped cardiac care centers, and many
skilled healthcare professionals, which are essential for the diagnosis and
treatment of cardiovascular diseases, often requiring intravascular stents. The
region has a significant prevalence of cardiovascular diseases, including
coronary artery disease, peripheral artery disease, and other conditions that
require stent implantation. Factors such as a sedentary lifestyle, poor dietary
habits, and the aging population contribute to this high incidence. And also
the region has been at the forefront of technological advancements in the field
of medical devices, including intravascular stents. Many leading stent
manufacturers and research institutions are in the region, driving innovation
and product development. North American healthcare systems tend to adopt new
medical technologies and treatments relatively early, contributing to a larger
market share for innovative stent products, such as drug-eluting stents and
bioresorbable stents. The presence of well-established health insurance systems
in North America helps patients access and afford stent procedures. This
insurance coverage encourages the adoption of stents as a treatment option.
Recent Developments
- In June 2024, Royal Philips, a global leader in health technology, announced the first implantation of the Duo Venous Stent System, an implantable medical device designed to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI). This follows the system's premarket approval (PMA) from the U.S. Food and Drug Administration (FDA).
Key Market Players
- Boston
Scientific Corporation
- Medtronic plc.
- Terumo
Medical Corporation
- Abbott Laboratories Inc.
- BIOTRONIK SE & Co. KG
- Stryker Corporation
- Microport
Scientific Corporation
- Stentys
S.A.
- HELLMAN & FRIEDMAN LLC
- B. Braun
SE
|
By Type
|
By Product
|
By End-Use
|
By Region
|
- Drug Eluting Stents
- Bare Metal Stents
- Bioabsorbable Stents
|
- Coronary Stents
- Peripheral Stents
|
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
|
- North America
- Asia-Pacific
- Europe
- South America
- Middle East & Africa
|
Report Scope:
In this report, the Global Intravascular Stents Market has been segmented into the following
categories, in addition to the industry trends which have also been detailed
below:
- Intravascular
Stents Market, By Type:
o Drug Eluting Stents
o Bare Metal Stents
o Bioabsorbable Stents
- Intravascular Stents
Market, By Product:
o Coronary Stents
o Peripheral Stents
- Intravascular Stents Market, By End-Use:
o Hospitals & Clinics
o Ambulatory Surgical Centers
o Others
- Intravascular Stents Market, By Region:
o North
America
§ United States
§ Canada
§ Mexico
o Asia Pacific
§ China
§ India
§ South
Korea
§ Australia
§ Japan
o Europe
§ Germany
§ France
§ United Kingdom
§ Spain
§ Italy
o South
America
§ Brazil
§ Argentina
§ Colombia
o Middle
East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive
Landscape
Company
Profiles: Detailed
analysis of the major companies presents in the Global Intravascular Stents
Market.
Available Customizations:
Global Intravascular Stents Market report with
the given market data, Tech Sci Research offers customizations according to a company's
specific needs. The following customization options are available for the
report:
Company Information
- Detailed analysis and profiling of additional market players (up to
five).
Global Intravascular Stents Market is an upcoming report to be released soon. If you wish an early delivery
of this report or want to confirm the date of release, please contact us at [email protected]